Evidence map›Paper›PMID 28295920›Full record

ArticleTraffic (Copenhagen, Denmark)2017

Importin β1 targeting by hepatitis C virus NS3/4A protein restricts IRF3 and NF-κB signaling of IFNB1 antiviral response.

Bridget Gagné, Nicolas Tremblay, Alex Y Park, Martin Baril, Daniel Lamarre

Open access · bronzeAbstract read
In one paragraph

Article in Traffic (Copenhagen, Denmark), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  3. Review
  4. HCV NS3/4A protease relocalizes CCTα to viral replication sites, enhancing phosphatidylcholine synthesis and viral replication.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bridget GagnéCentre de Recherche du CHUM (CRCHUM), Montréal, Canada.
Nicolas TremblayCentre de Recherche du CHUM (CRCHUM), Montréal, Canada.ORCID 0000-0003-4246-7189
Alex Y ParkCentre de Recherche du CHUM (CRCHUM), Montréal, Canada.
Martin BarilCentre de Recherche du CHUM (CRCHUM), Montréal, Canada.
Daniel LamarreCentre de Recherche du CHUM (CRCHUM), Montréal, Canada.
Centre Hospitalier de l’Université de Montréal · CA

Funding

CIHR
6 · The paper itself

Abstract

In this study, newly identified host interactors of hepatitis C virus (HCV) proteins were assessed for a role in modulating the innate immune response. The analysis revealed enrichment for components of the nuclear transport machinery and the crucial interaction with NS3/4A protein in suppression of interferon-β (IFNB1) induction. Using a comprehensive microscopy-based high-content screening approach combined to the gene silencing of nuclear transport factors, we showed that NS3/4A-interacting proteins control the nucleocytoplasmic trafficking of IFN regulatory factor 3 (IRF3) and NF-κB p65 upon Sendai virus (SeV) infection. Notably, importin β1 (IMPβ1) knockdown-a hub protein highly targeted by several viruses-decreases the nuclear translocation of both transcription factors and prevents IFNB1 and IFIT1 induction, correlating with a rapid increased of viral proteins and virus-mediated apoptosis. Here we show that NS3/4A triggers the cleavage of IMPβ1 and inhibits nuclear transport to disrupt IFNB1 production. Importantly, mutated IMPβ1 resistant to cleavage completely restores signaling, similar to the treatment with BILN 2061 protease inhibitor, correlating with the disappearance of cleavage products. Overall, the data indicate that HCV NS3/4A targeting of IMPβ1 and related modulators of IRF3 and NF-κB nuclear transport constitute an important innate immune subversion strategy and inspire new avenues for broad-spectrum antiviral therapies.

Indexed as

Signal TransductionAdaptor Proteins, Signal Transducingbeta KaryopherinsCarrier ProteinsDEAD-box RNA HelicasesHepacivirusHumansInterferon Regulatory Factor-3Intracellular Signaling Peptides and ProteinsKaryopherinsNF-kappa BNucleoside-TriphosphataseProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesAdaptor Proteins, Signal Transducingbeta KaryopherinsCarrier ProteinsDEAD-box RNA HelicasesInterferon Regulatory Factor-3Intracellular Signaling Peptides and ProteinsKaryopherinsKPNB1 protein, humanNF-kappa BNS3 protein, hepatitis C virusNS4A cofactor peptide, Hepatitis C virusNucleoside-TriphosphataseProtease InhibitorsSerine EndopeptidasesViral Nonstructural ProteinsViral ProteasesHCVimportin-αimportin-βIMPβ1/KPNB1innate antiviral immunityinterferon-βIRF3microscopy-based high-content screeningNF-κB p65NPCNS3/4A proteinnuclear pore complexnuclear translocationnucleocytoplasmic transportRNAi screenSeVvirus-host interaction

Identifiers

PMID28295920
PMCPMC7169781
OpenAlexW2610461060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.